The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system

被引:90
作者
Shea, John M.
Kechichian, Talar B.
Luberto, Chiara
Del Poeta, Maurizio
机构
[1] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Immunol & Microbiol, Charleston, SC 29425 USA
关键词
D O I
10.1128/IAI.00768-06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In recent years, sphingolipids have emerged as critical molecules in the regulation of microbial pathogenesis. In fungi, the synthesis of complex sphingolipids is important for the regulation of pathogenicity, but the role of sphingolipid degradation in fungal virulence is not known. Here, we isolated and characterized the inositol phosphosphingolipid-phospholipase C1 (ISC1) gene from the fungal pathogen Cryptococcus neoformans and showed that it encodes an enzyme that metabolizes fungal inositol sphingolipids. Isc1 protects C. neoformans from acidic, oxidative, and nitrosative stresses, which are encountered by the fungus in the phagolysosomes of activated macrophages, through a Pma1-dependent mechanism(s). In an immunocompetent mouse model, the C. neoformans Delta isc1 mutant strain is almost exclusively found extracellularly and in a hyperencapsulated form, and its dissemination to the brain is remarkably reduced compared to that of control strains. Interestingly, the dissemination of the C. neoformans Delta isc1 strain to the brain is promptly restored in these mice when alveolar macrophages are pharmacologically depleted or when infecting an immunodeficient mouse in which macrophages are not efficiently activated. These studies suggest that Isc1 plays a key role in protecting C. neoformans from the intracellular environment of macrophages, whose activation is important for preventing fungal dissemination of the Delta isc1 strain to the central nervous system and the development of meningoencephalitis.
引用
收藏
页码:5977 / 5988
页数:12
相关论文
共 50 条
[1]  
Ambesi A, 2000, J EXP BIOL, V203, P155
[2]   SUR1 (CSG1/BCL21), a gene necessary for growth of Saccharomyces cerevisiae in the presence of high Ca2+ concentrations at 37 degrees C, is required for mannosylation of inositolphosphorylceramide [J].
Beeler, TJ ;
Fu, D ;
Rivera, J ;
Monaghan, E ;
Gable, K ;
Dunn, TM .
MOLECULAR & GENERAL GENETICS, 1997, 255 (06) :570-579
[3]   Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells [J].
Blackstock, R ;
Murphy, JW .
INFECTION AND IMMUNITY, 2004, 72 (09) :5175-5180
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies [J].
Casadevall, A ;
Cleare, W ;
Feldmesser, M ;
Glatman-Freedman, A ;
Goldman, DL ;
Kozel, TR ;
Lendvai, N ;
Mukherjee, J ;
Pirofski, LA ;
Rivera, J ;
Rosas, AL ;
Scharff, MD ;
Valadon, P ;
Westin, K ;
Zhong, ZJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1437-1446
[6]  
CASADEVALL A, 1998, CRYPTOCOCCUS NEOFORM, P381
[7]   KILLING OF VIRULENT MYCOBACTERIUM-TUBERCULOSIS BY REACTIVE NITROGEN INTERMEDIATES PRODUCED BY ACTIVATED MURINE MACROPHAGES [J].
CHAN, J ;
XING, Y ;
MAGLIOZZO, RS ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1111-1122
[8]   Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier [J].
Charlier, C ;
Chrétien, F ;
Baudrimont, M ;
Mordelet, E ;
Lortholary, O ;
Dromer, F .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (02) :421-432
[9]   Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa [J].
Cheung, DOY ;
Halsey, K ;
Speert, DP .
INFECTION AND IMMUNITY, 2000, 68 (08) :4585-4592
[10]   ALKALINE-O-]N-TRANSACYLATION - A NEW METHOD FOR THE QUANTITATIVE DEACYLATION OF PHOSPHOLIPIDS [J].
CLARKE, NG ;
DAWSON, RMC .
BIOCHEMICAL JOURNAL, 1981, 195 (01) :301-306